Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Paratek Pharmaceuticals Inc
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients, ages 18 years or older who have signed the informed consent
Has a qualifying skin and skin structure infection
Female patients must not be pregnant at the time of enrollment
Must agree to a reliable method of birth control during the study and for 30 days following the last dose of study drug
You may not be if
Infections where the outcome is strongly influenced by factors other than protocol-defined treatment and procedures, that require antibacterial treatment for greater than 14 days
Evidence of significant immunological disease
Severe sepsis or septic shock
Has a history of hypersensitivity or allergic reaction to any tetracycline or to linezolid
Has received an investigational drug within past 30 days
Women who are pregnant or nursing
Clareo Health | Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
